DGX vs PFSI · P/E 22, rev $5.94B vs P/E 8.6, rev $25.6M
Quest Diagnostics Incorporated (DGX) versus PennyMac Finl Svcs Inc (PFSI) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
PennyMac Finl Svcs Inc (PFSI) is a mortgage finance company listed on NYSE.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported PFSI revenue for 2026-06-30 was $25.6M. Net income was $104.0M. PFSI currently screens at market cap $4.22B and trailing P/E 8.6.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. PFSI currently screens at market cap $4.22B and trailing P/E 8.6.
Not investment advice. Open the DGX and PFSI stock pages for the full models.
Not investment advice.